DrugMonitor™ Anti-Lumiliximab Antibody (VS-1224-YC693)
CAT#: VS-1224-YC693
Lumiliximab is a chimeric monoclonal antibody serving as an immunosuppressive drug, a primatized macaque/human anti-CD23 antibody for potentially treating allergic conditions. The DrugMonitor™ Anti-Lumiliximab Antibody (VS-1224-YC693) is an anti-drug antibody (ADA) against Lumiliximab. This drug-based antibody is raised in mice immunized with the Lumiliximab. The anti-Lumiliximab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Lumiliximab in samples.
Specifications
- Host Animal
- Mouse
- Specificity
- Lumiliximab
- Target
- Lumiliximab
- Immunogen
- Lumiliximab
- Type
- Mouse IgG
- Species Reactivity
- Human
- Purity
- >95%
- Purification
- Protein G
- Applications
- ELISA, PK/PD, ADA control
- Format
- Liquid
- Concentration
- Batch-dependent
- Buffer
- PBS, pH 7.4
- Preservative
- No preservatives
- Storage
- Store at 4°C for 1-2 weeks and at -20°C for 1 year. Avoid repeated freezing and thawing.
- Generic name
- Lumiliximab
- Drug Weight
- 47750.0 Da
- Formula
- C₂₁₁₅H₃₂₅₂N₅₅₆O₆₇₃S₁₆
REVIEWS AND Q&AS
CITATIONS
RESOURCES
DOWNLOADS
RELATED PRODUCTS
Inquiry
Navs
Customer Review
There are currently no Customer reviews or questions for VS-1224-YC693. Click the button above to contact us or submit your feedback about this product.
Submit Your Publication
Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.
Downloadable Resources
Download resources about recombinant antibody development and antibody engineering to boost your research.
Datasheet
MSDS
COA
Certificate of Analysis LookupTo download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number:
See other products for "lumiliximab"
Anti-CD23 Recombinant Antibody Lumiliximab(Lumiliximab)Recombinant chimeric (primate/human) antibody expressed in CHO. Lumiliximab is a monoclonal antibody that targets CD23. It acts as an immunomodulator. The drug is a chimeric antibody from Macaca irus and Homo sapiens.
Afuco™ Anti-CD23 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-760)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant chimeric (primate/human) antibody expressed in CHO. It is a monoclonal antibody that targets CD23. It acts as an immunomodulator. The drug is a chimeric antibody from Macaca irus and Homo sapiens.
Specific Inquiry
Add to compare
See Our Custom Production in Action
Popular Products
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: FC, IP, ELISA, Neut, FuncS, IF, ICC
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: WB, ELISA, FuncS, Inhib, PK, IP, SPR
-4.jpg)
Application: FC, FuncS, IA, IF, IP, IHC
Application: ELISA, WB, Microarray, Block
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
